|
|
J P Lebreton, F Joisel, J P Raoult, B Lannuzel, J P Rogez, G Humbert
J Clin Invest. 1979;
64(4):1118
doi:10.1172/JCI109551
Abstract |
Full text
| PDF

A
nonspecific opsonin function has been ascribed to human alpha 2 HS glycoprotein. Its serum level has been shown to be decreased in trauma patients. Recent studies from this laboratory revealed a heterogeneity among the products obtained in the course of the preparation of the protein. To date, no definitive agreement existed with regard to a molecular homogeneous entity of alpha 2 HS glycoprotein (Ba-alpha 2 glycoproteins). The purpose of the current work was to study the variations in serum level of alpha 2 HS in patients suffering from an acute inflammatory process of bacterial etiology and to determine whether a decrease in alpha 2 HS was accompanied by the appearance of fragments of this protein in the serum. A method of preparing alpha 2 HS was thus developed, using an immune absorbent as a final purification step. In an intermediary step of the preparation, alpha 2 HS was found to bind zinc when metal chelate affinity chromatography was employed. Immunologically and physico-chemically pure alpha 2 HS was obtained. The protein consists of a unique polypeptide chain of about 50,000 daltons and has a unique amino-terminal residue, alanine. However, the protein maintained its molecular integrity with difficulty, and spontaneous fragments ranging from 30,000 to less than 10,000 daltons were produced in some of the preparations. No major modification in the molecular structure of the protein was noted in the sera of subjects suffering from an acute inflammatory process. Serum level of alpha 2 HS and alpha 1 antitrypsin (AT)was determined in 23 patients. When the acute-phase (AP-)reactant alpha 1 AT was increased (difference with normal mean greater than +2 or +3 SD), the sera showed a large decrease in alpha 2 HS (difference with normal mean less than -2 or -3 SD). The serum level of alpha 2 HS, albumin, alpha 2 macroglobulin, and of positive AP-reactants, orosomucoidinal study of seven patients. The results were submitted to a principal components analysis. Alpha 2 HS showed a negative correlation with the AP-reactants alpha 1 AT, orosomucoid, and haptoglobin (P less than 0.05) and a positive correlation with albumin (P less than 0.05); these findings indicate that alpha 2 HS is a negative AP-reactant. In addition, analysis of the principal components confirms thestrong analogy between alpha 2 HS and albumin and indicates that serum level behavior of the AP-reactants during the course of the disease closely depends on the protein studied.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(85)
| Title and authors |
Publication |
Year |
Antibodies against acute phase proteins and their functions in the pathogenesis of disease: A collective profile of 25 different antibodies
Katja Lakota, Polona Zigon, Katjusa Mrak-Poljsak, Blaz Rozman, Yehuda Shoenfeld, Snezna Sodin-Semrl
|
Autoimmunity Reviews
|
2011 |
Dietary oil modifies the plasma proteome during aging in the rat
Mónica Santos-González, José López-Miranda, Francisco Pérez-Jiménez, Plácido Navas, José M. Villalba
|
AGE
|
2011 |
Long-Term Efficacy and Safety of the Small-Sized β2-Microglobulin Adsorption Column for Dialysis-Related Amyloidosis
Yuichiro Yamamoto, Nobuhito Hirawa, Satoshi Yamaguchi, Nariaki Ogawa, Hideyuki Takeda, Ken Shibuya, Kimiko Kawahara, Hirofumi Kojima, Yasushi Dobashi, Megumi Fujita, Kengo Azusima, Nobuko Miyazaki, Mayumi Kobayashi, Chinatsu Kobayashi, Akira Fujiwara, Jun Yuto, Sanae Saka, Keisuke Yatsu, Yoshiyuki Toya, Gen Yasuda, Toshimasa Ohnishi, Satoshi Umemura
|
Therapeutic Apheresis and Dialysis
|
2011 |
Serum fetuin-A and vitamin D in children with mild-to-severe chronic kidney disease: a cross-sectional study
J. Schaible, M. Wigger, H. Staude, E. Drueckler, G. Kundt, D. Haffner, D.-C. Fischer
|
Nephrology Dialysis Transplantation
|
2011 |
Fetuin-A Pretransplant Serum Levels, Kidney Allograft Function and Rejection Episodes: A 3-Year Posttransplantation Follow-Up
Marcel Roos, Falko M. Heinemann, Monika Lindemann, Peter A. Horn, Jens Lutz, Konrad Stock, Klaus Thürmel, Marcus Baumann, Oliver Witzke, Uwe Heemann
|
Kidney Blood Press Res
|
2011 |
Consequences of Chronic Inflammation in Peritoneal Dialysis
Angela Yee-Moon Wang
|
Seminars in Nephrology
|
2011 |
Serum fetuin-A in metabolic and inflammatory pathways in patients with myocardial infarction
Krisztián Vörös, László Gráf Jr, Zoltán Prohászka, László Gráf, Péter Szenthe, Edit Kaszás, Zoltán Böröcz, Károly Cseh, László Kalabay
|
European Journal of Clinical Investigation
|
2011 |
The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsis
Nermin A. H. Sadik, Waleed A. Mohamed, Mohamed I. Ahmed
|
Mol Cell Biochem
|
2011 |
Mechanisms and treatment of extraosseous calcification in chronic kidney disease
Markus Ketteler, Hansjörg Rothe, Thilo Krüger, Patrick H. Biggar, Georg Schlieper
|
Nat Rev Nephrol
|
2011 |
Effects of Lowering Dialysate Calcium Concentrations on Arterial Stiffness in Patients Undergoing Hemodialysis
Jwa-Kyung Kim, Sung Jin Moon, Hyeong Cheon Park, Jae Sung Lee, Soung Rok Sim, Sung Chang Bae, Sung Kyu Ha
|
Korean J Intern Med
|
2011 |
|